Treatment of Osteoporosis

Cotts and Cifu present research on the treatment of osteoporosis. They recommend patients with osteoporosis that they do not require BMO monitoring during treatment is based on low-quality evidence and an absence of evidence of benefit. Patients receiving antiresorptive therapy who do not show benef...

Full description

Saved in:
Bibliographic Details
Published in:JAMA : the journal of the American Medical Association 2018-03, Vol.319 (10), p.1040-1041
Main Authors: Cotts, Kamala Gullapalli, Cifu, Adam S
Format: Article
Language:English
Subjects:
Biocompatibility
Body mass index
Bone mineral density
Disease management
Fractures
Osteoporosis
Patient care planning
Patients
Xenoestrogens
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cotts and Cifu present research on the treatment of osteoporosis. They recommend patients with osteoporosis that they do not require BMO monitoring during treatment is based on low-quality evidence and an absence of evidence of benefit. Patients receiving antiresorptive therapy who do not show benefit in terms of BMD still obtain benefit in terms of fracture reduction. The guideline also recommends against use of estrogenic compound for osteoporosis.
ISSN:0098-7484
1538-3598
DOI:10.1001/jama.2017.21995